These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17709147)

  • 41. [Development of hygromycin-resistant packaging cell line for hepatitis B virus-derived vectors].
    Hu DR; Sun DX; Xiong JH; Wu GH; Hu XL; Li J; Fan GR; Han JQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):28-30. PubMed ID: 15340521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus resistance to nucleos(t)ide analogues.
    Zoulim F; Locarnini S
    Gastroenterology; 2009 Nov; 137(5):1593-608.e1-2. PubMed ID: 19737565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells.
    Guo JT; Zhou T; Guo H; Block TM
    Antiviral Res; 2007 Dec; 76(3):232-40. PubMed ID: 17897730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
    Tsukamoto Y; Ikeda S; Uwai K; Taguchi R; Chayama K; Sakaguchi T; Narita R; Yao WL; Takeuchi F; Otakaki Y; Watashi K; Wakita T; Kato H; Fujita T
    PLoS One; 2018; 13(5):e0197664. PubMed ID: 29782545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense oligodeoxynucleotides targeted against molecular chaperonin Hsp60 block human hepatitis B virus replication.
    Park SG; Lee SM; Jung G
    J Biol Chem; 2003 Oct; 278(41):39851-7. PubMed ID: 12869561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus X-DNA. A serum marker for early detection of resistance development during lamivudine therapy.
    Zhang W; Li YH; Zhu SJ; Zhang Y; Gong L; Wang SM; Hacker HJ; Schröder CH; Cheng DS; Feng YM
    Ann N Y Acad Sci; 2008 Aug; 1137():264-72. PubMed ID: 18837958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs.
    Wang P; Naduthambi D; Mosley RT; Niu C; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4642-7. PubMed ID: 21704526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium ions affect the hepatitis B virus core assembly.
    Choi Y; Gyoo Park S; Yoo JH; Jung G
    Virology; 2005 Feb; 332(1):454-63. PubMed ID: 15661175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
    Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
    J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro.
    Liu Y; Zhao Y; Zhai X; Feng X; Wang J; Gong P
    Bioorg Med Chem; 2008 Jul; 16(13):6522-7. PubMed ID: 18524601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation.
    Cao F; Jones S; Li W; Cheng X; Hu Y; Hu J; Tavis JE
    J Viral Hepat; 2014 Dec; 21(12):882-93. PubMed ID: 24401091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative.
    Li Y; Fu L; Yeo H; Zhu JL; Chou CK; Kou YH; Yeh SF; Gullen E; Austin D; Cheng YC
    Antivir Chem Chemother; 2005; 16(3):193-201. PubMed ID: 16004082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids.
    Wang YX; Wen YM; Nassal M
    J Virol; 2012 Sep; 86(18):10079-92. PubMed ID: 22787212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro.
    Xu J; Wang J; Deng F; Hu Z; Wang H
    Antiviral Res; 2008 Jun; 78(3):242-9. PubMed ID: 18313149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adeno-associated virus Rep78 protein inhibits Hepatitis B virus replication through regulation of the HBV core promoter.
    Liu T; Cong M; Wang P; Jia J; Liu Y; Hermonat PL; You H
    Biochem Biophys Res Commun; 2009 Jul; 385(1):106-11. PubMed ID: 19410559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B viruses: reverse transcription a different way.
    Nassal M
    Virus Res; 2008 Jun; 134(1-2):235-49. PubMed ID: 18339439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homoacyclovir analogues of unnatural bases and their activity against hepatitis B virus.
    el Ashry ES; Abdel-Rahman AA; Rashed N; Rasheed HA
    Pharmazie; 1999 Dec; 54(12):893-7. PubMed ID: 10631753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of novel hepatitis B virus capsid inhibitor using in silico screening.
    Hayakawa M; Umeyama H; Iwadate M; Tanahashi T; Yano Y; Enomoto M; Tamori A; Kawada N; Murakami Y
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1165-75. PubMed ID: 26095852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tenofovir for the treatment of hepatitis B virus.
    Jenh AM; Thio CL; Pham PA
    Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.